These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35494257)

  • 1. The Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient-Acceptable Symptomatic State after Medial Patellofemoral Ligament Reconstruction.
    Walsh JM; Huddleston HP; Alzein MM; Wong SE; Forsythe B; Verma NN; Cole BJ; Yanke AB
    Arthrosc Sports Med Rehabil; 2022 Apr; 4(2):e661-e678. PubMed ID: 35494257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient-Acceptable Symptomatic State for Commonly Used Patient-Reported Outcomes in Recurrent Patellar Instability Patients After Medial Patellofemoral Ligament Reconstruction and Tibial Tubercle Transfer.
    Qiao Y; Wu C; Wu X; Li Z; Chen J; Xu C; Zhao S; Zhao J
    Arthroscopy; 2024 Jan; 40(1):115-123. PubMed ID: 37419222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Clinically Significant Patient-Reported Outcomes After Primary Arthroscopic Partial Meniscectomy.
    Gowd AK; Lalehzarian SP; Liu JN; Agarwalla A; Christian DR; Forsythe B; Cole BJ; Verma NN
    Arthroscopy; 2019 May; 35(5):1567-1575.e3. PubMed ID: 31000386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing the Minimal Clinically Important Difference and Patient-Acceptable Symptomatic State After Arthroscopic Meniscal Repair and Associated Variables for Achievement.
    Maheshwer B; Wong SE; Polce EM; Paul K; Forsythe B; Bush-Joseph C; Bach BR; Yanke AB; Cole BJ; Verma NN; Chahla J
    Arthroscopy; 2021 Dec; 37(12):3479-3486. PubMed ID: 33964390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Minimally Clinically Important Difference and Substantial Clinical Benefit in Anterior Cruciate Ligament Reconstruction: A Time-to-Achievement Analysis.
    Beletsky A; Naami E; Lu Y; Polce EM; Chahla J; Okoroha KR; Bush-Joseph C; Bach B; Yanke A; Forsythe B; Cole BJ; Verma NN
    Orthopedics; 2021; 44(5):299-305. PubMed ID: 34590953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing Clinically Significant Outcomes After Meniscal Allograft Transplantation.
    Liu JN; Gowd AK; Redondo ML; Christian DR; Cabarcas BC; Yanke AB; Cole BJ
    Orthop J Sports Med; 2019 Jan; 7(1):2325967118818462. PubMed ID: 30643837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Patient-relevant Thresholds and Change Scores for the HOOS JR and KOOS JR Anchored on the Patient-acceptable Symptom State Question.
    Dekhne MS; Fontana MA; Pandey S; Driscoll DA; Lyman S; McLawhorn AS; MacLean CH
    Clin Orthop Relat Res; 2024 Apr; 482(4):688-698. PubMed ID: 37773026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the Minimal Clinically Important Difference and Patient Acceptable Symptom State for Microfracture of the Knee: A Psychometric Analysis at Short-term Follow-up.
    Chahla J; Kunze KN; Tauro T; Wright-Chisem J; Williams BT; Beletsky A; Yanke AB; Cole BJ
    Am J Sports Med; 2020 Mar; 48(4):876-883. PubMed ID: 32058796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Specific Variables Associated with Failure to Achieve Clinically Significant Outcomes After Meniscal Allograft Transplantation at Minimum 5 Year Follow-Up.
    Wagner KR; Kaiser JT; Knapik DM; Condron NB; Gilat R; Meeker ZD; Sivasundaram L; Yanke AB; Cole BJ
    Arthroscopy; 2023 Nov; 39(11):2327-2338. PubMed ID: 37116548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinically Important Difference and Patient Acceptable Symptomatic State for Commonly Used Patient-Reported Outcomes After Knee Cartilage Repair.
    Chahal J; Lansdown DA; Davey A; Davis AM; Cole BJ
    Am J Sports Med; 2021 Jan; 49(1):193-199. PubMed ID: 33226845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Thresholds for the Patient Acceptable Symptom State for the IKDC Subjective Knee Form and KOOS for Patients Who Underwent ACL Reconstruction.
    Muller B; Yabroudi MA; Lynch A; Lai CL; van Dijk CN; Fu FH; Irrgang JJ
    Am J Sports Med; 2016 Nov; 44(11):2820-2826. PubMed ID: 27474383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Area Deprivation Index is Associated With Not Achieving the Patient-acceptable Symptom State After TKA.
    Hadad MJ; Pasqualini I; Klika AK; Jin Y; Deren ME; Krebs VE; Murray TG; Piuzzi NS
    Clin Orthop Relat Res; 2024 Aug; 482(8):1428-1438. PubMed ID: 38569119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Are the Minimal and Substantial Improvements in the HOOS and KOOS and JR Versions After Total Joint Replacement?
    Lyman S; Lee YY; McLawhorn AS; Islam W; MacLean CH
    Clin Orthop Relat Res; 2018 Dec; 476(12):2432-2441. PubMed ID: 30179951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis-Specific Thresholds of the Minimal Clinically Important Difference and Patient Acceptable Symptom State for KOOS After Total Knee Arthroplasty.
    Emara AK; Pasqualini I; Jin Y; Klika AK; Orr MN; Rullán PJ; Piuzzi NS;
    J Bone Joint Surg Am; 2024 May; 106(9):793-800. PubMed ID: 38381811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing Clinically Significant Outcomes After Anterior Cruciate Ligament Reconstruction in Pediatric Patients.
    Maheshwer B; Polce EM; Parvaresh KC; Paul K; Yanke AB; Forsythe B; Bush-Joseph CA; Bach BR; Cole BJ; Verma NN; Kogan M; Chahla J
    J Pediatr Orthop; 2022 Jul; 42(6):e641-e648. PubMed ID: 35297390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal Clinically Important Differences and Substantial Clinical Benefit in Patient-Reported Outcome Measures after Autologous Chondrocyte Implantation.
    Ogura T; Ackermann J; Barbieri Mestriner A; Merkely G; Gomoll AH
    Cartilage; 2020 Oct; 11(4):412-422. PubMed ID: 30221977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing patient-centered metrics for the knee injury and osteoarthritis outcome score following medial unicompartmental knee arthropalsty.
    Pasqualini I; Mariorenzi M; Klika AK; Rullán PJ; Zhang C; Murray TG; Molloy RM; Piuzzi NS
    Knee; 2024 Jan; 46():1-7. PubMed ID: 37972421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Minimal Clinically Important Difference and Substantial Clinical Benefit in the Patient-Reported Outcome Measures of Patients Undergoing Osteochondral Allograft Transplantation in the Knee.
    Ogura T; Ackermann J; Mestriner AB; Merkely G; Gomoll AH
    Cartilage; 2021 Jan; 12(1):42-50. PubMed ID: 30463426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Acceptable Symptom State Thresholds for IKDC-SKF and KOOS at the 10-Year Follow-up After Anterior Cruciate Ligament Injury: A Study From the Delaware-Oslo ACL Cohort.
    Urhausen AP; Grindem H; H Ingelsrud L; Roos EM; Silbernagel KG; Snyder-Mackler L; Risberg MA
    Orthop J Sports Med; 2024 May; 12(5):23259671241250025. PubMed ID: 38827138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the minimal clinically important difference for IKDC and KOOS scores for patients undergoing tibial tubercle osteotomy for patellofemoral pain or instability.
    Retzky JS; Shah AK; Neijna AG; Rizy ME; Gomoll AH; Strickland SM
    J Exp Orthop; 2024 Jul; 11(3):e12115. PubMed ID: 39076849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.